Alector (ALEC) Change in Accured Expenses (2018 - 2026)
Alector's (ALEC) quarterly Change in Accured Expenses came in at -$2.8 million in Q2 2026, up 26.87% year-over-year from -$2.2 million in Q2 2025, and up 74.89% quarter-over-quarter from -$11.0 million in Q1 2026.
Analysis
Alector (ALEC) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Change in Accured Expenses for 9 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 26.87% year-over-year to -$2.8 million in Q2 2026; TTM through Jun 2026 was -$10.2 million, a 60.8% decrease from a year earlier, with the FY2025 full-year figure at -$12.9 million, down 3895.29% from the prior year.
- Change in Accured Expenses was -$2.8 million for Q2 2026 at Alector, up from -$11.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $8.0 million in Q3 2023 and troughed at -$12.7 million in Q1 2025.
- A 5-year average of -$1.5 million and a median of -$1.6 million in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses jumped 823.83% in 2023 and slumped 900.21% in 2025, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $4.6 million in 2022, then tumbled by 145.79% to -$2.1 million in 2023, then jumped by 420.84% to $6.8 million in 2024, then tumbled by 84.0% to $1.1 million in 2025, then slumped by 354.18% to -$2.8 million in 2026.
- The last three Change in Accured Expenses figures came in at -$2.8 million (Q2 2026), -$11.0 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 852.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 338.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 222.50 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 492.70 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 11.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -49.70 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -2.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.77 Mn |
| Mar 31, 2026 | -11.02 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | -3.79 Mn |
| Mar 31, 2025 | -12.72 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | -10.30 Mn |
| Dec 31, 2023 | -2.12 Mn |
| Sep 30, 2023 | 8.05 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | -7.02 Mn |
| Dec 31, 2022 | 4.63 Mn |
| Sep 30, 2022 | -1.11 Mn |
| Jun 30, 2022 | -2.79 Mn |
| Mar 31, 2022 | -3.38 Mn |
| Dec 31, 2021 | 7.88 Mn |
| Sep 30, 2021 | -1.26 Mn |